{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:54:56Z","timestamp":1794441296615,"version":"4.9.1"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,6,17]]},"abstract":"<jats:sec id=\"ab-joi250023-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Recent evidence from a quasi-experiment in Wales showed that herpes zoster (HZ) vaccination appears to prevent or delay dementia. Exploiting a similar quasi-experiment in Australia, this study investigated the effect of HZ vaccination on dementia occurrence in a different population and health system setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the effect of HZ vaccination on the probability of receiving a new diagnosis of dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In Australia, starting November 1, 2016, live attenuated HZ vaccination was provided free to individuals aged 70 to 79 years through primary care clinicians. Thus, individuals whose 80th birthday was just a few weeks before November 1, 2016, never became eligible, whereas those whose 80th birthday was just a few weeks later were eligible. The key strength of this quasi-experiment is that one would not expect that these comparison groups who differ in age only minutely would, on average, differ in any health characteristics and behaviors. Primary health care records were analyzed with week-of-birth information from 65 general practices across Australia, using a regression discontinuity design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Eligibility for HZ vaccination based on date of birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-8\">\n                    <jats:title>Main Outcome<\/jats:title>\n                    <jats:p>New diagnoses of dementia as recorded in primary care electronic health record data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this sample of 101\u202f219 patients, 52.7% were women and mean age was 62.6 years (SD, 9.3 years) as of November 1, 2016. Individuals born just before vs just after the date-of-birth eligibility threshold (November 2, 1936) for HZ vaccination were well balanced in their past preventive health services uptake and past chronic disease diagnoses. There was an abrupt increase of 16.4 percentage points (95% CI, 13.2-19.5;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) in the probability of ever receiving HZ vaccination between patients born shortly before vs shortly after the date-of-birth eligibility threshold. The eligibility rules of the HZ vaccination program thus created comparison groups born just on either side of the date-of-birth eligibility threshold who were likely similar to each other, except for a large difference in their probability of receiving the intervention (HZ vaccination) of interest. This study found that eligibility for HZ vaccination (ie, being born shortly after vs shortly before November 2, 1936) decreased the probability of receiving a new dementia diagnosis during 7.4 years by 1.8 percentage points (95% CI, 0.4-3.3 percentage points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01). Being eligible for HZ vaccination did not affect the probability of taking up other preventive health services (including other vaccinations) or the probability of receiving a diagnosis of common chronic conditions other than dementia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-joi250023-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>By taking advantage of a quasi-experiment and corroborating findings from Wales in a different population, this study provides evidence of the potential benefits of HZ vaccination for dementia that is more likely to be causal than that of more commonly conducted associational studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.5013","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:30:18Z","timestamp":1745429418000},"page":"2083","source":"Crossref","is-referenced-by-count":83,"title":["Herpes Zoster Vaccination and Dementia Occurrence"],"prefix":"10.1001","volume":"333","author":[{"given":"Michael","family":"Pomirchy","sequence":"first","affiliation":[{"name":"Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bommer","sequence":"additional","affiliation":[{"name":"Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Pradella","sequence":"additional","affiliation":[{"name":"Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California"},{"name":"Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany"},{"name":"Gutenberg School of Management and Economics, Mainz University, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Michalik","sequence":"additional","affiliation":[{"name":"Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California"},{"name":"Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Peters","sequence":"additional","affiliation":[{"name":"Ageing and Neurodegeneration, Neuroscience Research Australia, Sydney, New South Wales, Australia"},{"name":"School of Psychology, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"Ageing Futures Institute, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"Neurology, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Geldsetzer","sequence":"additional","affiliation":[{"name":"Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California"},{"name":"The Phil and Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Stanford University, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"},{"name":"Chan Zuckerberg Biohub\u2013San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi250023r1","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer\u2019s disease.","volume":"51","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"joi250023r2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11910-018-0863-1","article-title":"Viral hypothesis and antiviral treatment in Alzheimer\u2019s disease.","volume":"18","author":"Devanand","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"joi250023r3","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41380-021-01138-6","article-title":"The viral hypothesis: how herpesviruses may contribute to Alzheimer\u2019s disease.","volume":"26","author":"Wainberg","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"12","key":"joi250023r4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer\u2019s disease.","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi250023r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115109","article-title":"Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease.","volume":"44","author":"Hyde","year":"2025","journal-title":"Cell Rep"},{"issue":"10","key":"joi250023r6","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/S1473-3099(19)30742-X","article-title":"Vaccinology: time to change the paradigm?","volume":"20","author":"Benn","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"joi250023r7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40264-023-01295-3","article-title":"Implications of non-specific effects for testing, approving, and regulating vaccines.","volume":"46","author":"Benn","year":"2023","journal-title":"Drug Saf"},{"issue":"8","key":"joi250023r8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines.","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"joi250023r9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia.","author":"Eyting","journal-title":"Nature"},{"issue":"2","key":"joi250023r10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JAD-221231","article-title":"The impact of routine vaccinations on Alzheimer\u2019s disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching.","volume":"95","author":"Harris","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"joi250023r11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045871","article-title":"Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study\u2014results from the UK Biobank cohort.","volume":"11","author":"Lophatananon","year":"2021","journal-title":"BMJ Open"},{"issue":"11","key":"joi250023r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257405","article-title":"Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts.","volume":"16","author":"Scherrer","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"joi250023r13","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12293","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020.","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"joi250023r14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/jgs.17606","article-title":"Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations.","volume":"70","author":"Wiemken","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"joi250023r15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1186\/s12889-023-16768-4","article-title":"The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink.","volume":"23","author":"Lophatananon","year":"2023","journal-title":"BMC Public Health"},{"key":"joi250023r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112411","article-title":"Associations of infections and vaccines with Alzheimer\u2019s disease point to a role of compromised immunity rather than specific pathogen in AD.","volume":"190","author":"Ukraintseva","year":"2024","journal-title":"Exp Gerontol"},{"issue":"6","key":"joi250023r17","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.21873\/invivo.12622","article-title":"Herpes zoster vaccination reduces risk of dementia.","volume":"35","author":"Lehrer","year":"2021","journal-title":"In Vivo"},{"issue":"3","key":"joi250023r18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/jech-2021-217090","article-title":"Drug prescriptions and dementia incidence: a medication-wide association study of 17000 dementia cases among half a million participants.","volume":"76","author":"Wilkinson","year":"2022","journal-title":"J Epidemiol Community Health"},{"key":"joi250023r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126673","article-title":"Recombinant zoster vaccine and the risk of dementia.","volume":"46","author":"Tang","year":"2025","journal-title":"Vaccine"},{"issue":"10","key":"joi250023r20","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia.","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"joi250023r21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"10248","key":"joi250023r22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"joi250023r23","doi-asserted-by":"publisher","first-page":"ii30","DOI":"10.1093\/ageing\/afae030","article-title":"Nutrition for dementia prevention: a state of the art update for clinicians.","volume":"53","author":"Townsend","year":"2024","journal-title":"Age Ageing"},{"issue":"20","key":"joi250023r25","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1016\/j.vaccine.2020.03.036","article-title":"Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program.","volume":"38","author":"Lin","year":"2020","journal-title":"Vaccine"},{"issue":"10","key":"joi250023r26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.vaccine.2021.01.067","article-title":"Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia.","volume":"39","author":"Lin","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"joi250023r29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"Alzheimer\u2019s disease facts and figures.","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"joi250023r30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies.","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"joi250023r31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","article-title":"Person-specific contribution of neuropathologies to cognitive loss in old age.","volume":"83","author":"Boyle","year":"2018","journal-title":"Ann Neurol"},{"issue":"24","key":"joi250023r32","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1002\/sim.9861","article-title":"A guide to regression discontinuity designs in medical applications.","volume":"42","author":"Cattaneo","year":"2023","journal-title":"Stat Med"},{"issue":"3","key":"joi250023r34","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/rssa.12812","article-title":"Regression discontinuity designs for time-to-event outcomes: an approach using accelerated failure time models.","volume":"185","author":"Adeleke","year":"2022","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"1","key":"joi250023r36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1037\/met0000118","article-title":"Statistical power for the comparative regression discontinuity design with a nonequivalent comparison group.","volume":"23","author":"Tang","year":"2018","journal-title":"Psychol Methods"},{"issue":"12","key":"joi250023r37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.31128\/AJGP-01-18-4472","article-title":"Colorectal cancer screening in Australia: an update.","volume":"47","author":"Parkin","year":"2018","journal-title":"Aust J Gen Pract"},{"issue":"1-2","key":"joi250023r39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jns.2012.07.059","article-title":"Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years\u2019 duration.","volume":"323","author":"Silver","year":"2012","journal-title":"J Neurol Sci"},{"key":"joi250023r40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jns.2016.07.035","article-title":"Successful antiviral treatment after 6 years of chronic progressive neurological disease attributed to VZV brain infection.","volume":"368","author":"Gilden","year":"2016","journal-title":"J Neurol Sci"},{"issue":"1","key":"joi250023r41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001103","article-title":"Targeted RNA sequencing of VZV-infected brain vascular adventitial fibroblasts indicates that amyloid may be involved in VZV vasculopathy.","volume":"9","author":"Bubak","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"joi250023r42","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/infdis\/jiy425","article-title":"Varicella zoster virus vasculopathy.","volume":"218","author":"Nagel","year":"2018","journal-title":"J Infect Dis"},{"issue":"11","key":"joi250023r43","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/01.wnl.0000304747.38502.e8","article-title":"The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.","volume":"70","author":"Nagel","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"joi250023r44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/WNL.0b013e3182267bfa","article-title":"Varicella zoster virus vasculopathy: analysis of virus-infected arteries.","volume":"77","author":"Nagel","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"joi250023r45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.0b013e31827b1ab9","article-title":"Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.","volume":"80","author":"Nagel","year":"2013","journal-title":"Neurology"},{"key":"joi250023r46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2014lessons from pathology.","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med"},{"issue":"22","key":"joi250023r47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"joi250023r48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/vaccines9060679","article-title":"Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer\u2019s disease (AD): underwhelming evidence against.","volume":"9","author":"Itzhaki","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"joi250023r49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3233\/JAD-220287","article-title":"Potential involvement of varicella zoster virus in Alzheimer\u2019s disease via reactivation of quiescent herpes simplex virus type 1.","volume":"88","author":"Cairns","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"joi250023r50","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2216625","article-title":"Do vaccinations influence the development of Alzheimer disease?","volume":"19","author":"Bukhbinder","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"joi250023r52","first-page":"820","article-title":"Data extraction from electronic health records\u2014existing tools may be unreliable and potentially unsafe.","volume":"42","author":"Liaw","year":"2013","journal-title":"Aust Fam Physician"},{"key":"joi250023r53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/978-1-61499-078-9-219","article-title":"The University of NSW electronic practice based research network: disease registers, data quality and utility.","volume":"178","author":"Taggart","year":"2012","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"joi250023r54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12911-024-02560-w","article-title":"Undercounting diagnoses in Australian general practice: a data quality study with implications for population health reporting.","volume":"24","author":"Canaway","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"joi250023r55","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12879-016-1820-8","article-title":"Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake.","volume":"16","author":"Dyda","year":"2016","journal-title":"BMC Infect Dis"},{"key":"joi250023r33","doi-asserted-by":"crossref","DOI":"10.1017\/9781108684606","volume-title":"A Practical Introduction to Regression Discontinuity Designs: Foundations","author":"Cattaneo","year":"2019"},{"key":"joi250023r35","doi-asserted-by":"crossref","DOI":"10.1017\/9781009441896","volume-title":"A Practical Introduction to Regression Discontinuity Designs: Extensions","author":"Cattaneo","year":"2024"},{"key":"joi250023r24","unstructured":"National Centre for Immunisation Research and Surveillance. Shingles vaccination program a positive: report. Published April 5, 2019. Accessed May 15, 2024. https:\/\/ncirs.org.au\/shingles-vaccination-program-positive-report"},{"key":"joi250023r27","unstructured":"Australian Government Department of Health and Aged Care. National Immunisation Program. Published August 14, 2023. Accessed June 21, 2024. https:\/\/www.health.gov.au\/our-work\/national-immunisation-program"},{"key":"joi250023r28","unstructured":"PenCS. Practice cloud. Published May 15, 2024. Accessed May 15, 2024. https:\/\/www.pencs.com.au\/"},{"key":"joi250023r38","unstructured":"Australian Government Department of Health and Aged Care. BreastScreen Australia program. Published March 18, 2024. Accessed June 21, 2024. https:\/\/www.health.gov.au\/our-work\/breastscreen-australia-program"},{"key":"joi250023r51","unstructured":"Australian Institute of Health and Welfare. Dementia in Australia. Published March 28, 2024. Updated September 13, 2024. Accessed June 21, 2024. https:\/\/www.aihw.gov.au\/reports\/dementia\/dementia-in-aus\/contents\/summary"},{"key":"joi250023r56","unstructured":"Australian Government Department of Health and Aged Care. National Immunisation Program\u2014changes to shingles vaccination from 1 November 2023. Published October 13, 2023. Accessed March 30, 2025. https:\/\/www.health.gov.au\/news\/national-immunisation-program-changes-to-shingles-vaccination-from-1-november-2023"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2833335\/jama_pomirchy_2025_oi_250023_1749674948.53204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:00:37Z","timestamp":1750158037000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2833335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":56,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,6,17]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.5013","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}